S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains

GlobeStar Therapeutics (GSTC) SEC Filings & 10K Form

$0.0009
0.00 (0.00%)
(As of 04/17/2024 ET)

Recent GlobeStar Therapeutics SEC Filings

DateFilerForm TypeView
02/15/2024
10:33 AM
GlobeStar Therapeutics Corp (Filer)
GlobeStar Therapeutics (Filer)
Form NT 10-Q
01/19/2024
4:13 PM
GlobeStar Therapeutics Corp (Filer)
GlobeStar Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
11/13/2023
11:32 AM
GlobeStar Therapeutics Corp (Filer)
GlobeStar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2023
3:31 PM
GlobeStar Therapeutics Corp (Filer)
GlobeStar Therapeutics (Filer)
Form NT 10-Q
06/27/2023
4:11 PM
GlobeStar Therapeutics Corp (Filer)
GlobeStar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/22/2023
4:18 PM
GlobeStar Therapeutics Corp (Filer)
GlobeStar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2023
12:29 PM
Chicoski Robert (Reporting)
GlobeStar Therapeutics Corp (Issuer)
GlobeStar Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/03/2023
12:34 PM
Chicoski Robert (Reporting)
GlobeStar Therapeutics Corp (Issuer)
GlobeStar Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (OTCMKTS:GSTC) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners